Hansen EL et al. (1971) Experientia "Effect of insect hormones on nematodes in axenic culture."

Hansen EL, Buecher EJ

[Experientia, 1971]

Insect juvenile hormones (JH) or JH mimetics have been shown to affect development of nematodes: Trichinella spiralis larvae and fourth stage Phocanema decipiens were inhibited, and abnormal morphology was seen in Heterodera schactii. The effects of insect hormones and analogues on development of several free-living and parasitic nematodes cultured axenically are described in the present paper.

Sim C et al. (2013) Front Physiol "Insulin signaling and the regulation of insect diapause."

Denlinger DL, Sim C

[Front Physiol, 2013]

A rich chapter in the history of insect endocrinology has focused on hormonal control of diapause, especially the major roles played by juvenile hormones (JHs), ecdysteroids, and the neuropeptides that govern JH and ecdysteroid synthesis. More recently, experiments with adult diapause in Drosophila melanogaster and the mosquito Culex pipiens, and pupal diapause in the flesh fly Sarcophaga crassipalpis provide strong evidence that insulin signaling is also an important component of the regulatory pathway leading to the diapause phenotype. Insects produce many different insulin-like peptides (ILPs), and not all are involved in the diapause response; ILP-1 appears to be the one most closely linked to diapause in C. pipiens. Many steps in the pathway leading from perception of daylength (the primary environmental cue used to program diapause) to generation of the diapause phenotype remain unknown, but the role for insulin signaling in mosquito diapause appears to be upstream of JH, as evidenced by the fact that application of exogenous JH can rescue the effects of knocking down expression of ILP-1 or the Insulin Receptor. Fat accumulation, enhancement of stress tolerance, and other features of the diapause phenotype are likely linked to the insulin pathway through the action of a key transcription factor, FOXO. This review highlights many parallels for the role of insulin signaling as a regulator in insect diapause and dauer formation in the nematode Caenorhabditis elegans.

Fodor A et al. (1989) General & Comparative Endocrinology "Effects of precocene analogs on the nematode Caenorhabditis remanei (var. Bangaloreiensis). 2. Competitions with a juvenile hormone analog (methoprene)."

Timar T, Fodor A

[General & Comparative Endocrinology, 1989]

Fourteen 7-alkoxy-2,2-dimethylchromenes were synthetized and studied in JH competition experiments: prococenes (Ps) PI and PII, and synthetic analogs (PAs) including (i) three with both antiallatal and P-like activities: 7-ethoxy-PII (7-EPII); 7-(prop-2-ynyloxy)-2,2-dimethylchromene (PPI); and 6-methoxy-7-(prop-2-yynyloxy)-2,2-dimethylchromene (PPIII); (ii) six without antiallatal activity, exerting P-like activity in nematodes; and (iii) three without either antiallatal or P-like activity, but with a strong nematocidal effect. Within the dose range 8-1000 ug/ml, different concentrations of each PA were applied to nematode growth medium which did or did not contain 1000 ug methoprene (a juvenile hormone analog JHA)/ml. Plates inoculated with Caenorhabditis embryos were incubated and scored for developmentally affected survivors. The JHA did not compete with any PA mentioned as (iii). It competed moderately with some nonantiallatal PAs (8-Me-PPI, 8-MeO-PPI, and 3,4-diCl-PPI) with strong P-like and nematocidal activities. The JHA competed most efficiently with all Ps, antiallatal PAs, and two nonantiallatal PAs (PPII and thio-PI) which exerted severe P-like activities in nematodes. Parameters assumed to be indicators of the P-like (rather than nematocidal) activity of the PAs proved more sensitive to the JHA than those of nematocidal activity. Whether the JH-compensable P-like activity of some PAs can be regarded as a real anti-JH action needs further clarification.

Landis GN et al. (2020) J Gerontol A Biol Sci Med Sci "Metabolic Signatures of Life Span Regulated by Mating, Sex Peptide and Mifepristone/RU486 in Female Drosophila melanogaster."

Abdelmesieh M, Patel P, Wang T, Tower J, Wang L, Fan Y, Promislow DEL, Doherty DV, Lee S, Vroegop J, Wu J, Shen J, Landis GN, Yen CA, Wang I, Curran SP

[J Gerontol A Biol Sci Med Sci, 2020]

Mating and transfer of male Sex Peptide (SP), or transgenic expression of SP, causes inflammation and decreased life span in female Drosophila. Mifepristone rescues these effects, yielding dramatic increases in life span. Here targeted metabolomics data were integrated with further analysis of extant transcriptomic data. Each of seven genes positively correlated with life span were expressed in the brain or eye, and involved regulation of gene expression and signaling. Genes negatively correlated with life span were preferentially expressed in midgut and involved protein degradation, amino acid metabolism, and immune response. Across all conditions, life span was positively correlated with muscle breakdown product 1/3-methylhistadine and purine breakdown product urate, and negatively correlated with tryptophan breakdown product kynurenic acid, suggesting a SP-induced shift from somatic maintenance/turnover pathways to the costly production of energy and lipids from dietary amino acids. Some limited overlap was observed between genes regulated by mifepristone and genes known to be regulated by ecdysone, however, mifepristone was unable to compete with ecdysone for activation of an ecdysone-responsive transgenic reporter. In contrast, genes regulated by mifepristone were highly enriched for genes regulated by Juvenile Hormone (JH), and mifepristone rescued the negative effect of JH analog methoprene on life span in adult virgin females. The data indicate that mifepristone increases life span and decreases inflammation in mated females by antagonizing JH signaling downstream of male SP. Finally, mifepristone increased life span of mated, but not unmated, C. elegans, in two of three trials, suggesting possible evolutionary conservation of mifepristone mechanisms.

Fodor A et al. (1987) Worm Breeder's Gazette "competition of exogenous methoprene and precocenes in nematodes: the end of the story."

Timar T, Hosztafi S, Dinya Z, Fodor A, Kiss I

[Worm Breeder's Gazette, 1987]

We have accomplished a ten year long project aimed to learn whether competition between the juvenile hormone (JH) analogue methoprene (JHA) and precocenes (P's) (chromene derivatives capable to destruct the JH producing organ (CA) in sensitive insect species tissue specifically) in C. elegans (Fodor, et. al., Gen. Comp. Endcr. 46: p. 99 (1982)) can or cannot be explained by a comparable 'anti-JH' action of P's in nematodes. Neither JH or CA like organ has been discovered in nematodes so far. There are only a few indirect data showing that insect juvenile hormones may influence certain nematodes pathogenizing insects. We adopted a 'structure/activity' approach including design, synthesis and test P analogues on nematodes in the presence and absence of JHA. If (at least part of) those analogues which capable to destruct the CA of a sensitive insect (Locusta migratoria) were also effective in nematodes and their effect could be compensated by JHA exogenously, then this hormone (analogue) should play a physiological role in the P-poisoned nematodes. If those P's could be competed by JHA, which proved effective (as 'anti-JH' compounds) in insects, but those which exerted only aspecific toxicity could not be, then it would be logical to suggest, that P's are the same kind of 'suicide compounds' for nematodes as for insects. More than 200 P derivatives were synthesized (Tim r, Hosztafi) and tested on C. elegans (Fodor) and L. migratoria (Kiss). After a detailed quantitative structure/activity relation (QSAR) analysis ( Dinya, et. al., QSAR Strat. Des. Bioact. Compd. Proc. Eur. Symp. Struct.-Act. Relat. 5th (1984) Publ. 1985) several new P analogue were designed, synthesized and tested on L. migratoria and on C. remanei var. Bangaloriensis. (We choose this nematode strain because half of its population consists of males, therefore it is easy to distinguish male adultoids from other type of retarded worms.) Altogether, 121 molecules were retested C. remanei and 17 of them was found to exert some significant biological effect. These compounds were retested again several times both in the absence and in the presence of 1 mg/ml NGM dose of JHA: altogether, more that 144,000 C. remanei embryos were counted, treated and scored afterwards. The tests on nematodes were carried out as described in our attached paper. The most characteristic data concerning precocene activity in nematodes were the following: (1) LC50: the half lethal dose (in g/ml) at which half of the embryos develops to worms (calculated by probit analysis); (2) AD50: the dose ( g/ml) at which half of the embryos develops to normal adults; (3) EC50: the dose ( g/ml) at which half of the nematodes on the plates found as 'normal' fertile adults; (4) The maximum frequency of 'adultoid mini worms' during the experiments. [See Figures 1- 2] The main conclusions are the following: About structure/activity relations: (1) All the three (P1-P3) precocene is effective in nematodes and their effects can be compensated by exogenous JHA. (2) The longer the chain of the R7 substituent the less the effect of the compounds in nematodes. (3) The 7-proparglyoxy analogues are much more effective in nematodes than any other C7 substituted compound. (compare P1 to TT51; P2 to K460; P3 to TT80; TT56 to TT58 or 3,4-diCl-P1 (inactive) to FI121.) (4) The asymmetrically disubstituted analogues are much more effective than the symmetrically disubstituted ones (compare TT80 to K460). It is true, if R7 is longer than R6. (5) Me substitution at C5 position inactivates the originally potent P's (compare TT58 to TT51) but restore the activity of originally inactive (for instance, 7-sBuO-P1) analogues (compare it to TT56). 8-MeO substitution eliminate specific P activity (compare TT51 to K464). (6) Both 8-Me and 8-MeO substitution increase toxic rather than JH compatible biological activity of P's. 8-MeO analogues are more toxic than 8-Me ones, but the consequences of the action of 8-MeO compounds in nematodes can be cured more efficiently by JHA than those concerning 8-Me compounds (compare TT100 to K475). About JHA competition experiments: JHA competed the effects of all precocenes which effected both insects and nematodes. However, the data concerning K354 and FI121 show, that there are analogues which effective only in nematodes and their effects can also be cured by exogenous JHA. Although there are aspecifically toxic analogues (like K454 or 2,3,5-triMe-7 propargO-P1) which cannot be compensated by methoprene, we cannot conclude, that our data unambiguously support the idea of existence JH-like hormones in nematodes. It seems very probable, however, that JH-like compounds can interfere with the lethal metabolism of P's.

Fodor A et al. (1989) Gen Comp Endocrinol "Effects of precocene analogs on the nematode Caenorhabditis remanei (var. Bangaloreiensis). I. Structure/activity relations."

Sebok P, Varga E, Hosztafi S, Fodor A, Timar T, Kiss I, Soos J

[Gen Comp Endocrinol, 1989]

Precocenes (PI and PII) and 114 of their analogs (PAs) were synthetized and tested on C. remanei embryos for their precocene-like (P-like) activities resulting in unusual development at sublethal doses. The P-like activity was quantitated by plotting the probit of the percentage of the developmentally affected survivors against the (log) dose to obtain the EC plot and the half effective concentration (EC50). All five PAs (PI, PII, 7-ethoxy-PII, 7-(prop-2-ynyloxy)-PI, and 6-methoxy-7-(prop-2-ynyloxy)-PII) which exert both antiallatal activity in insects and P-like activity in nematodes are 7-alkoxy-substituted 2,2-dimethylchromenes. Both activities can be enhanced by an additional 6-MeO-substitution or by an asymmetric 6,7-dialkoxy-substitution, on condition that R-7 is longer than R-6. There are many more similarities than dissimilarities in the structural requirements needed for antiallatal and P-like activities. All but three nonantiallatal PAs effective in nematodes are 7-prop-2-ynyloxy-substituted; two are symmetrically 6,7-disubstituted, and one is heterosubstituted (thio-PI). All PAs with antiallatal but without P-like activity are 7-monosubstituted with a relatively long alkoxy group. Certain substitutions favor antiallatal activity and others P-like activity. The severe nematocidal effect of 6,7-methylenedioxy-2,2-dimethylchromene (inert in insects) is not accompanied by P-like activity. The present findings lend some indirect support to the supposition that JH-producing cells and/or JH-dependent function(s) might

Soumbey-Alley E et al. (2004) J Med Entomol "Uptake of Onchocerca volvulus (Nematoda: Onchocercidae) by Simulium (Diptera: Simuliidae) is not strongly dependent on the density of skin microfilariae in the human host."

Boatin BA, Remme JH, Habbema JD, Nagelkerke NJ, Basanez MG, de Vlas SJ, Soumbey-Alley E, Borsboom GJ, Bissan Y

[J Med Entomol, 2004]

The relation between the number of microfilariae (mf) ingested by host-seeking vectors of human onchocerciasis and skin mf load is an important component of the population biology of Onchocerca volvulus, with implications for disease control and evaluation of the risk of transmission recrudescence. The microsimulation model ONCHOSIM has been used to assess such risk in the area of the Onchocerciasis Control Program (OCP) in West Africa, based on a strongly nonlinear relation between vector mf uptake and human mf skin density previously published. However, observed levels of recrudescence have exceeded predictions, warranting a recalibration of the model. To this end, we present the results of a series of fly-feeding experiments carried out in savanna and forest localities of West Africa. Flies belonging to Simulium damnosum s.s., S. sirbanum, S. soubrense, and S. leonense were fed on mf carriers and dissected to assess the number of ingested mf escaping imprisonment by the peritrophic matrix (the number of exo-peritrophic mf), a predictor of infective larval output. The method of instrumental variables was used to obtain (nearly) unbiased estimates of the parameters of interest, taking into account error in the measurement of skin mf density. This error is often neglected in these types of studies, making it difficult to ascertain the degree of density-dependence truly present in the relation between mf uptake and skin load. We conclude that this relation is weakly (yet significantly) nonlinear in savanna settings but indistinguishable from linearity in forest vectors. Exo-peritrophic mf uptake does not account for most of the density dependence in the transmission dynamics of the parasite as previously thought. The number of exo-mf in forest simuliids is at least five times higher than in the savanna vectors. Parasite abundance in human onchocerciasis is regulated by poorly known mechanisms operating mainly on other stages of the lifecycle.

Vinkeles Melchers NVS et al. (2019) Clin Infect Dis "Projected number of people with onchocerciasis-loiasis co-infection in Africa, 1995 to 2025."

Vinkeles Melchers NVS, Coffeng LE, Tekle AH, Boussinesq M, Stolk WA, Remme JH, Pion SDS, Wanji S, Zoure HGM, Pedrique B

[Clin Infect Dis, 2019]

BACKGROUND: Onchocerciasis elimination through mass drug administration (MDA) is hampered by co-endemicity of Loa loa in Africa, as people with high L. loa microfilariae (mf) density can develop serious adverse events (SAEs) after ivermectin treatment. We assessed the geographical overlap of onchocerciasis and loiasis prevalence and estimated the number of co-infected individuals at risk of post-ivermectin SAEs in West and Central Africa from 1995 to 2025. METHODS: Focussing on regions with suspected loiasis transmission in 14 African countries, we overlaid pre-control maps of loiasis and onchocerciasis prevalence to calculate pre-control prevalence of co-infection by 5x5 km pixel, distinguishing different categories of L. loa mf intensity. Using statistical and mathematical models, we predicted the prevalence of both infections and co-infection for 2015 and 2025, accounting for the impact of MDA with ivermectin. RESULTS: The number of people infected with onchocerciasis was predicted to decline from almost 19 million in 1995 to 4 million in 2025. Of these, 137,000 people were estimated to also have L. loa hypermicrofilaraemia (20,000 L. loa mf/mL) in 1995, declining to 31,000 in 2025. In 2025, 92.8% of co-infected cases with loiasis hypermicrofilaraemia are predicted to live in hypoendemic areas currently not targeted for MDA. CONCLUSIONS: Loiasis co-infection is a major concern for onchocerciasis elimination in Africa. We predict that under current strategies, at least 31,000 co-infected people will still require treatment for onchocerciasis in 2025 while being at risk of SAEs, justifying continued efforts in research and development for safer drugs and control strategies.

Diawara L et al. (2009) PLoS Negl Trop Dis "Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal."

Diawara L, Traore MO, Remme JH, Sarr MD, Touree S, Goita SF, Bissan Y, Doumbia K, Mounkoro K, Seck AF, Badji A, Konate L, Toe L

[PLoS Negl Trop Dis, 2009]

BACKGROUND: Mass treatment with ivermectin is a proven strategy for controlling onchocerciasis as a public health problem, but it is not known if it can also interrupt transmission and eliminate the parasite in endemic foci in Africa where vectors are highly efficient. A longitudinal study was undertaken in three hyperendemic foci in Mali and Senegal with 15 to 17 years of annual or six-monthly ivermectin treatment in order to assess residual levels of infection and transmission and test whether ivermectin treatment could be safely stopped in the study areas. METHODOLOGY/PRINCIPAL FINDINGS: Skin snip surveys were undertaken in 126 villages, and 17,801 people were examined. The prevalence of microfilaridermia was <1% in all three foci. A total of 157,500 blackflies were collected and analyzed for the presence of Onchocerca volvulus larvae using a specific DNA probe, and vector infectivity rates were all below 0.5 infective flies per 1,000 flies. Except for a subsection of one focus, all infection and transmission indicators were below postulated thresholds for elimination. Treatment was therefore stopped in test areas of 5 to 8 villages in each focus. Evaluations 16 to 22 months after the last treatment in the test areas involved examination of 2,283 people using the skin snip method and a DEC patch test, and analysis of 123,000 black flies. No infected persons and no infected blackflies were detected in the test areas, and vector infectivity rates in other catching points were <0.2 infective flies per 1,000. CONCLUSION/SIGNIFICANCE: This study has provided the first empirical evidence that elimination of onchocerciasis with ivermectin treatment is feasible in some endemic foci in Africa. Although further studies are needed to determine to what extent these findings can be extrapolated to other endemic areas in Africa, the principle of elimination has been established. The African Programme for Onchocerciasis Control has adopted an additional objective to assess progress towards elimination endpoints in all onchocerciasis control projects and to guide countries on cessation of treatment where feasible.

Voegtlin, Thomas et al. (2011) International Worm Meeting "An Open-Source Neuromechanical Model of C. Elegans Locomotion."

Cohen, Netta, Voegtlin, Thomas

[International Worm Meeting, 2011]

A neuromechanical model of locomotion in C. elegans was recently proposed by Jordan H. Boyle [1]. One of the main results is that both swimming and crawling can be generated by a single neural circuit, reflexively modulated by the environment. This supports the known experimental results showing that different forms of C. elegans forward locomotion (e.g., swimming and crawling) can be described by a modulation of a single biomechanical gait [2]. The modelling result illustrates the importance and the potential of neuromechanical simulations for the analysis of the worm's behaviour. In order to continue this work, and to make it usable by a broader audience, we have developed a similar neuromechanical model of the worm using CLONES. CLONES (Closed Loop Neural Simulation) is an open source framework for neuromechanical simulations. CLONES implements a communication interface between a neural simulator, called BRIAN [3], and a physics engine for biomedical applications, called SOFA [4]. BRIAN and SOFA are open-source simulators that are easy to use and provide high performance. Our implementation of the worm's locomotion reproduces the neural model described in [1]. However, there are two key differences between the original physical model and our implementation. Firstly, Boyle's model considers that the body of the worm has zero mass (a low Reynolds number approximation). In contrast, the SOFA simulator allows us to integrate equations with mass and inertia. Secondly, the original model uses rigid rods of fixed length orthogonal to the body axis (approximating the incompressibility of the body due to high internal pressure). In SOFA rigid rods are modeled as springs of very high stiffness. The physical system simulated in SOFA is described using a XML syntax. The neural network model interpreted by BRIAN is written in Python, using MATLAB-like syntax. Thus, the model is completely interpreted, and it is possible to visualize/interact with the simulation during runtime. Physical environments containing obstacles or chemical concentration gradients can be defined easily. References 1. Boyle JH: C. elegans locomotion: an integrated approach. PhD thesis, university of Leeds, 2009 2. Berri S, Boyle JH, Tassieri M, Hope IA and Cohen N, Forward locomotion of the nematode C. elegans is achieved through modulation of a single gait HFSP J 3:186, 2009; 3. Goodman DF, Brette R: Brian: a simulator for spiking neural networks in Python. Front Neuroinform 2:5, 2008 4. Allard J, Cotin S, Faure F, Bensoussan PJ, Poyer F, Duriez C, Delingette H, Grisoni L: SOFA - an Open Source Framework for Medical Simulation. Medicine Meets Virtual Reality (MMVR'15), pp. 13-18, 2007.